Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)
Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)
Recruiting · NCT06294600 · Registry updated 2025-12-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT) | Community-Acquired Infections, Community-Acquired Pneumonia, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Phase 3 | 2025-12-16 | NCT06294600 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hellenic Institute for the Study of Sepsis | 8 |
24 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.